ULTRAGENYX PHARMACEUTICAL INC. Class of Warrant or Right, Outstanding
ULTRAGENYX PHARMACEUTICAL INC. (RARE) had Class of Warrant or Right, Outstanding of 149.70 thousand shares as of 2015-12-31, per its 10-K filed 2016-02-26.
Discontinued › Notes
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2016-02-26
- 2015-12-31: Class of Warrant or Right, Outstanding 149.70K shares.
- 2015-09-30: Class of Warrant or Right, Outstanding 149.70K shares.
- 2015-06-30: Class of Warrant or Right, Outstanding 149.70K shares.
- 2014-12-31: Class of Warrant or Right, Outstanding 324.35K shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2015-12-31 | 149.70K shares 10-K · filed 2016-02-26 |
| 2015-09-30 | 149.70K shares 10-Q · filed 2015-11-10 |
| 2015-06-30 | 149.70K shares 10-Q · filed 2015-08-14 |
| 2014-12-31 | 324.35K shares 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |